Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Nitroxynil
1. Nitroxynil
2. 1689-89-0
3. 4-hydroxy-3-iodo-5-nitrobenzonitrile
4. Dovenix
5. Benzonitrile, 4-hydroxy-3-iodo-5-nitro-
6. Nitroxinil [inn]
7. Deldrax
8. 4-hydroxy-3-iodo-5-nitro-benzonitrile
9. Mfcd00070776
10. 9l0exq7125
11. Nitroxinil (inn)
12. Nitroxinyl
13. Nitroxinilo
14. Nitroxinilum
15. 4-cyano-2-iodo-6-nitrophenol
16. Nitroxinilum [inn-latin]
17. Nitroxinilo [inn-spanish]
18. Ccris 5743
19. Nitroxinil [inn:ban]
20. Einecs 216-884-8
21. Brn 2213717
22. Unii-9l0exq7125
23. Deldrax (tn)
24. Nitroxynil [mi]
25. Nitroxinil [mart.]
26. Trodax [veterynary] (tn)
27. Mls006011503
28. Schembl166956
29. Zinc1823
30. Chembl2104730
31. Dtxsid9075117
32. Albb-028654
33. Bcp13892
34. Akos000276265
35. Ac-9329
36. Hy-w049875
37. Ks-1307
38. Smr000797772
39. Sy110145
40. Bb 0241976
41. Cs-0102838
42. Ft-0633772
43. En300-55806
44. D08278
45. Nitroxinil, Vetranal(tm), Analytical Standard
46. 689n890
47. A811045
48. Sr-01000944912
49. Q-201481
50. Q2680251
51. Sr-01000944912-1
52. Brd-k23850772-001-01-0
53. Z1250208635
Molecular Weight | 290.01 g/mol |
---|---|
Molecular Formula | C7H3IN2O3 |
XLogP3 | 2.3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 289.91884 g/mol |
Monoisotopic Mass | 289.91884 g/mol |
Topological Polar Surface Area | 89.8 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 256 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antiplatyhelmintic Agents
Agents used to treat cestode, trematode, or other flatworm infestations in man or animals. (See all compounds classified as Antiplatyhelmintic Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
59
PharmaCompass offers a list of Nitroxinil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nitroxinil manufacturer or Nitroxinil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nitroxinil manufacturer or Nitroxinil supplier.
PharmaCompass also assists you with knowing the Nitroxinil API Price utilized in the formulation of products. Nitroxinil API Price is not always fixed or binding as the Nitroxinil Price is obtained through a variety of data sources. The Nitroxinil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dovenix manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dovenix, including repackagers and relabelers. The FDA regulates Dovenix manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dovenix API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dovenix manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dovenix supplier is an individual or a company that provides Dovenix active pharmaceutical ingredient (API) or Dovenix finished formulations upon request. The Dovenix suppliers may include Dovenix API manufacturers, exporters, distributors and traders.
click here to find a list of Dovenix suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dovenix written confirmation (Dovenix WC) is an official document issued by a regulatory agency to a Dovenix manufacturer, verifying that the manufacturing facility of a Dovenix active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dovenix APIs or Dovenix finished pharmaceutical products to another nation, regulatory agencies frequently require a Dovenix WC (written confirmation) as part of the regulatory process.
click here to find a list of Dovenix suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dovenix as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dovenix API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dovenix as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dovenix and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dovenix NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dovenix suppliers with NDC on PharmaCompass.
Dovenix Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dovenix GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dovenix GMP manufacturer or Dovenix GMP API supplier for your needs.
A Dovenix CoA (Certificate of Analysis) is a formal document that attests to Dovenix's compliance with Dovenix specifications and serves as a tool for batch-level quality control.
Dovenix CoA mostly includes findings from lab analyses of a specific batch. For each Dovenix CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dovenix may be tested according to a variety of international standards, such as European Pharmacopoeia (Dovenix EP), Dovenix JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dovenix USP).